147 related articles for article (PubMed ID: 25865944)
21. Ph-positive and -negative myeloproliferative syndromes may co-exist.
Mauro MJ; Loriaux M; Deininger MW
Leukemia; 2004 Jul; 18(7):1305-7. PubMed ID: 15103389
[No Abstract] [Full Text] [Related]
22. [Emergence of mutation in the colony-stimulating factor 3 receptor gene during follow-up of unclassifiable myeloproliferative neoplasm].
Harada S; Okada K; Yokoyama S; Hidaka D; Hayase E; Onozawa M; Goto H; Hashimoto D; Kahata K; Endo T; Teshima T
Rinsho Ketsueki; 2021; 62(11):1609-1614. PubMed ID: 34866084
[TBL] [Abstract][Full Text] [Related]
23. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
Hall J; Foucar K
Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
[TBL] [Abstract][Full Text] [Related]
24. [Chronic myeloid leukemia without Philadelphia chromosome (Ph-negative CML)].
Haus O
Acta Haematol Pol; 1993; 24(3):221-5. PubMed ID: 8249537
[TBL] [Abstract][Full Text] [Related]
25. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literature.
Wang L; Du F; Zhang HM; Wang HX
Braz J Med Biol Res; 2015 Jul; 48(7):583-7. PubMed ID: 26017341
[TBL] [Abstract][Full Text] [Related]
27. Genomics of chronic neutrophilic leukemia.
Maxson JE; Tyner JW
Blood; 2017 Feb; 129(6):715-722. PubMed ID: 28028025
[TBL] [Abstract][Full Text] [Related]
28. Molecular diagnosis of Philadelphia negative CML using the polymerase chain reaction and DNA analysis: clinical features and course of M-bcr negative and M-bcr positive CML.
Dobrovic A; Morley AA; Seshadri R; Januszewicz EH
Leukemia; 1991 Mar; 5(3):187-90. PubMed ID: 2013977
[TBL] [Abstract][Full Text] [Related]
29. An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T.
Talati C; Padron E
Curr Hematol Malig Rep; 2016 Dec; 11(6):425-433. PubMed ID: 27664113
[TBL] [Abstract][Full Text] [Related]
30. [Molecular biologic study in chronic myelogenous leukemia and its related disorders].
Ohyashiki JH; Ohyashiki K; Toyama K
Rinsho Ketsueki; 1988 Jul; 29(7):1010-7. PubMed ID: 3184468
[No Abstract] [Full Text] [Related]
31. Prevalence and impact of colony stimulating factor 3 receptor (CSF3R) mutations among Egyptian acute myeloid leukemia patients.
Aref S; El-Ghonemy M; Abouzeid T; El-Sabbagh A; El-Baiomy M
Leuk Res; 2014 Jun; 38(6):722-5. PubMed ID: 24746896
[TBL] [Abstract][Full Text] [Related]
32. Clinical course and molecular features in 21 patients with atypical chronic myeloid leukemia.
Koldehoff M; Steckel NK; Hegerfeldt Y; Ditschkowski M; Beelen DW; Elmaagacli AH
Int J Lab Hematol; 2012 Feb; 34(1):e3-5. PubMed ID: 21707937
[No Abstract] [Full Text] [Related]
33. [Demonstration of BCR-ABL rearrangement in a patient with apparently Ph-negative chronic myeloid leukemia of 15 years' duration].
Valiente A; Outeriño J; Martín Calderín F; Benítez J
Sangre (Barc); 1990 Dec; 35(6):481-3. PubMed ID: 2087668
[TBL] [Abstract][Full Text] [Related]
34. Isolated thrombocytosis as first sign of chronic myeloid leukemia with e6a2 BCR/ABL fusion transcript, JAK2 negativity and complete response to imatinib.
Breccia M; Cannella L; Diverio D; Streponi P; Nanni M; Stefanizzi C; Natalino F; Mecarocci S; Alimena G
Leuk Res; 2008 Jan; 32(1):177-80. PubMed ID: 17688946
[TBL] [Abstract][Full Text] [Related]
35. The Philadelphia chromosome negative chronic myeloproliferative disorders: a practical overview.
Tefferi A
Mayo Clin Proc; 1998 Dec; 73(12):1177-84. PubMed ID: 9868417
[TBL] [Abstract][Full Text] [Related]
36. Atypical chronic myeloid leukemias.
Oscier D
Pathol Biol (Paris); 1997 Sep; 45(7):587-93. PubMed ID: 9404484
[TBL] [Abstract][Full Text] [Related]
37. Introduction to 'A special spotlight review series on BCR-ABL-negative myeloproliferative neoplasms'.
Tefferi A; Constantinescu SN
Leukemia; 2008 Jan; 22(1):1. PubMed ID: 18197171
[No Abstract] [Full Text] [Related]
38. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
[TBL] [Abstract][Full Text] [Related]
39. Mutations galore in myeloproliferative neoplasms: would the real Spartacus please stand up?
Tefferi A
Leukemia; 2011 Jul; 25(7):1059-63. PubMed ID: 21750560
[No Abstract] [Full Text] [Related]
40. Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders.
Pikman Y; Levine RL
Curr Opin Oncol; 2007 Nov; 19(6):628-34. PubMed ID: 17906464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
